{"id":142746,"date":"2023-02-24T05:15:00","date_gmt":"2023-02-24T10:15:00","guid":{"rendered":"https:\/\/44.250.171.167\/?p=142746"},"modified":"2023-02-24T08:13:07","modified_gmt":"2023-02-24T13:13:07","slug":"earnings-summary-of-indoco-remedies-limited-for-q3-fy23","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-summary-of-indoco-remedies-limited-for-q3-fy23\/","title":{"rendered":"Earnings Summary Of Indoco Remedies Limited For Q3 FY23"},"content":{"rendered":"<p>Indoco Remedies (NSE: INDOCO) is a leading Indian pharmaceutical company that operates in both domestic and international markets. The company has a diverse product portfolio that includes prescription drugs, over-the-counter (OTC) medicines, and veterinary products. Indoco Remedies has a strong presence in India and operates in more than 80 countries worldwide.<\/p>\n<p><strong>Quarterly Earnings Summary:<\/strong><\/p>\n<ul>\n<li>Indoco Remedies reported a consolidated revenue of \u20b9411.15 crore for Q3 FY 2023, an increase of 18% compared to the same quarter of the previous year.<\/li>\n<li>The company&#8217;s net profit for Q3 FY 2023 stood at \u20b928.14 crore, a decline from Net Profit of \u20b933 crore in the same quarter of the previous year.<\/li>\n<li>The company&#8217;s domestic business recorded a growth of 11%, while the international business grew by 26% during the quarter.<\/li>\n<li>The Earnings Per Share was \u20b93.05 for this quarter.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Indoco Remedies (NSE: INDOCO) is a leading Indian pharmaceutical company that operates in both domestic and international markets. The company has a diverse product portfolio that includes prescription drugs, over-the-counter (OTC) medicines, and veterinary products. Indoco Remedies has a strong presence in India and operates in more than 80 countries worldwide. Quarterly Earnings Summary: Indoco [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-142746","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":149793,"url":"https:\/\/alphastreet.com\/india\/indoco-remedies-ltd-q1-fy24-38-fall-in-profits\/","url_meta":{"origin":142746,"position":0},"title":"Indoco Remedies Ltd Q1 FY24; 38% fall in Profits","author":"Hardik Bhandare","date":"July 25, 2023","format":false,"excerpt":"Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Financial Results: Indoco Remedies Ltd reported Revenues for Q1FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-191.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-191.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-191.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-191.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-191.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-191.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":155287,"url":"https:\/\/alphastreet.com\/india\/indoco-remedies-ltd-q2fy24-30-fall-in-profits\/","url_meta":{"origin":142746,"position":1},"title":"Indoco Remedies Ltd Q2FY24; 30% fall in Profits","author":"Hardik Bhandare","date":"October 25, 2023","format":false,"excerpt":"Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Financial Results: Indoco Remedies Ltd reported Revenues for Q2FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-111.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-111.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-111.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-111.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-111.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-111.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162910,"url":"https:\/\/alphastreet.com\/india\/indoco-remedies-ltd-q4fy24-15-fall-in-profits\/","url_meta":{"origin":142746,"position":2},"title":"Indoco Remedies Ltd Q4FY24; 15% fall in Profits","author":"Divyansh_Kasana","date":"July 10, 2024","format":false,"excerpt":"Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Financial Results: Indoco Remedies Ltd reported Revenues for Q4FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-83.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-83.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-83.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-83.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-83.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-83.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":179364,"url":"https:\/\/alphastreet.com\/india\/indoco-remedies-q3-revenue-slips-as-losses-widen-despite-operating-recovery\/","url_meta":{"origin":142746,"position":3},"title":"Indoco Remedies Q3 Revenue Slips as Losses Widen Despite Operating Recovery","author":"Staff Correspondent","date":"February 3, 2026","format":false,"excerpt":"Indoco Remedies Limited (NSE:INDOCO) closed at \u20b9235.00 on February 3, 2026, up 10.88% from the previous close of \u20b9211.94, surging after Q3 FY26 results announced on February 2 showed consolidated revenue of \u20b9389.6 crore (up 7% YoY) and EBITDA growth of 29% to \u20b925.9 crore despite a net loss of\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":139138,"url":"https:\/\/alphastreet.com\/india\/indoco-remedies-limited-indoco-q3-fy23-earnings-concall-transcript\/","url_meta":{"origin":142746,"position":4},"title":"Indoco Remedies Limited (INDOCO) Q3 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"January 24, 2023","format":false,"excerpt":"Indoco Remedies Limited (NSE: INDOCO) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Aditi Panandikar\u00a0--\u00a0Managing Director Sundeep V. Bambolkar\u00a0--\u00a0Joint Managing Director Analysts: Cyndrella Carvalho\u00a0--\u00a0JM Financial -- Analyst Aditya Khemka\u00a0--\u00a0InCred Financial Services -- Analyst Sudarshan Padmanabhan\u00a0--\u00a0JM Financial PMS -- Analyst Mitesh Shah\u00a0--\u00a0Nirmal Bang Securities -- Analyst Aejas Lakhani\u00a0--\u00a0Unifi Capital\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":179585,"url":"https:\/\/alphastreet.com\/india\/indoco-remedies-limited-indoco-q3-2026-earnings-call-transcript\/","url_meta":{"origin":142746,"position":5},"title":"Indoco Remedies Limited (INDOCO) Q3 2026 Earnings Call Transcript","author":"News desk","date":"February 4, 2026","format":false,"excerpt":"Indoco Remedies Limited (NSE: INDOCO) Q3 2026 Earnings Call dated Feb. 03, 2026 Corporate Participants: Pramod Ghorpade \u2014 President, Finance and Group Chief Financial Officer Aditi Panandikar \u2014 Managing Director Analysts: Unidentified Participant Umesh Laddha \u2014 Analyst Pratik Kothari \u2014 Analyst Kenil Mehta \u2014 Analyst Ankit Gupta \u2014 Analyst Maulik\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=142746"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142746\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=142746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=142746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=142746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}